Biostate AI is a startup with a mission to develop generative AI that can benefit all of human health. Our approach is to build a cross-species AI that deeply understands the dynamics of living organisms on a systems biology level. linkedin.com/in/ashgopi/rec…

𝐖𝐡𝐚𝐭 𝐢𝐬 𝐁𝐢𝐨𝐬𝐭𝐚𝐭𝐞, 𝐚𝐧𝐝 𝐡𝐨𝐰 𝐝𝐨𝐞𝐬 𝐁𝐢𝐨𝐬𝐭𝐚𝐭𝐞 𝐀𝐈 𝐰𝐨𝐫𝐤? Our CEO Dave Zhang explains: - A "Biostate" is your body’s molecular snapshot - Biostate AI predicts your health outcomes, helping us understand your body under different conditions.

🎉 Exciting Milestone at Biostate AI: Bayosthiti Officially Incorporated! We’re thrilled to reflect on an incredible achievement—last month, our Indian subsidiary, Bayosthiti, was officially incorporated! This accomplishment wouldn't have been possible without the relentless

🚀 We’re officially LIVE on Wefunder! 🚀 Over the past year, we’ve been building something truly special, and we’re thrilled to invite you to be part of this journey. Biostate AI is transforming medicine with AI-driven precision healthcare, and now, you can help shape the

🔬Biostate AI Weekly Tech Insight Revolutionizing Alzheimer's Detection with Blood Tests A groundbreaking study in JAMA has unveiled the potential of multi-modal blood biomarkers for the early detection of Alzheimer's disease, bringing us closer to minimally invasive screening

🚀 Exciting Update: Biostate AI's Wefunder Campaign Featured on KingsCrowd! We are thrilled to announce that Biostate AI's ongoing Wefunder campaign has been spotlighted in a recent article by KingsCrowd, a leading platform for startup investment insights. This feature

Major Expansion: Biostate AI Launches Joint Venture in India! 🌏 Exciting news from Biostate AI! We've officially established our joint venture in India – Bayosthiti AI is now incorporated and operational with a fully equipped laboratory facility ready to serve the region's

🚀 Major Partnership Alert: Biostate AI Joins Forces with Accelerated Cure Project to Transform MS Research! We’re excited to share a groundbreaking partnership with the Accelerated Cure Project (ACP)—a leading non-profit dedicated to improving multiple sclerosis (MS) diagnosis

🧬 Biostate AI Weekly Tech Insight A New Era of Early Disease Detection A new study in The New England Journal of Medicine shows that a simple blood test could one day detect diseases like prostate cancer, Alzheimer’s, and kidney disease years before symptoms appear.

🧬 Biostate AI Weekly Tech Insight New Frontiers in Colorectal Cancer Genomics A major international study just published in Nature has delivered the most comprehensive genomic and transcriptomic analysis of colorectal cancer (CRC) to date—analyzing samples from over 1,000

🚀 Our tech is real. Our impact is growing... ⏳ This is the Final Month to Join Us After raising over $8M from top investors, we’re closing this opportunity soon. If you’ve been considering investing—now is the time. We opened this round to let everyday investors like you

🔬 Biostate Weekly Tech Insight How Antisense RNAs Are Shaping the Future of Gene Therapy Researchers from the University of Göttingen have uncovered a novel gene regulation mechanism involving antisense RNAs, offering a new frontier in precision medicine, gene therapy, and

🌍 This Earth Day, we’re celebrating the deep connection between the health of our planet and the health of every living cell. At Biostate AI, we believe healing starts from within—from the RNA that shapes life itself. That’s why we developed our patented BIRT technology: to

We’re Live in 1 Hour – Don’t Miss the Biostate AI Webinar! We’re going live in just 1 hour for our investor webinar — and there’s still time to join! 🗓️ Wednesday, April 23rd 🕙 11:00 AM PT (California Time) 📍 Join the webinar here → app.livestorm.co/biostate-ai/in… What we’ll cover:

All Hands, All In. Celebrating Collaboration and Innovation 🌱 Last week, the Biostate AI team came together for our April All Hands Meeting in Houston — two full days packed with strategy, science, and synergy. From cross-team updates on BIRT RNAseq and global

🚨 Today’s the Final Day to Join Our Journey After months of incredible momentum, our public investment round closes tonight. We’ve been honored by the overwhelming support from individual and institutional investors who believe in our mission Here’s what we’ve built so far:

🚀 Biostate AI Raises $12M in Series A Funding! 🚀 We are beyond excited to announce that Biostate AI has successfully raised $12M in Series A funding, led by Accel, with continued support from our amazing investors, Matte Venture Partners, Catapult VC, Gaingels, Mana Ventures,